A detailed history of Elevatus Welath Management transactions in Danaher Corp stock. As of the latest transaction made, Elevatus Welath Management holds 3,413 shares of DHR stock, worth $789,358. This represents 0.31% of its overall portfolio holdings.

Number of Shares
3,413
Previous 3,379 1.01%
Holding current value
$789,358
Previous $844 Million 12.4%
% of portfolio
0.31%
Previous 0.32%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$239.25 - $280.76 $8,134 - $9,545
34 Added 1.01%
3,413 $949 Million
Q2 2024

Aug 14, 2024

BUY
$235.51 - $267.98 $942 - $1,071
4 Added 0.12%
3,379 $844 Million
Q1 2024

May 10, 2024

BUY
$224.58 - $256.19 $673 - $768
3 Added 0.09%
3,375 $843 Million
Q4 2023

Feb 12, 2024

BUY
$185.1 - $233.13 $6,293 - $7,926
34 Added 1.02%
3,372 $780 Million
Q3 2023

Nov 14, 2023

BUY
$233.08 - $265.59 $22,841 - $26,027
98 Added 3.02%
3,338 $828 Million
Q2 2023

Aug 08, 2023

BUY
$224.99 - $256.14 $728,967 - $829,893
3,240 New
3,240 $778 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Elevatus Welath Management Portfolio

Follow Elevatus Welath Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elevatus Welath Management, based on Form 13F filings with the SEC.

News

Stay updated on Elevatus Welath Management with notifications on news.